Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
about
Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-AnalysisEvolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targetsA novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice.Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individualsThe HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus MacaquesHLA class I transgenic mice: development, utilisation and improvement.Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccineA comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopesIdentification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIVProcessing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes.CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes.Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.QSAR, DFT and molecular modeling studies of peptides from HIV-1 to describe their recognition properties by MHC-I.Immune hierarchy among HIV-1 CD8+ T cell epitopes delivered by dendritic cells depends on MHC-I binding irrespective of mode of loading and immunization in HLA-A*0201 mice.Of mice and humans: how good are HLA transgenic mice as a model of human immune responses?Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
P2860
Q28070121-B951E0E0-115A-4211-8CD2-120B72AA72B2Q30366017-8FD680C0-9FD5-417A-9DD0-F8A6A1699FA9Q33504189-A35C240F-593B-4A8B-9FEB-AE3C4039B63DQ34742548-D6B5933E-1259-4B33-B464-F85083EDB4D5Q35105393-D6B11F0A-1655-465E-B3ED-5C21A895FDCEQ35826692-34861134-74D8-4286-927F-5F16494B3222Q36194073-B7209F33-3507-43C3-87B5-CB506310A0E3Q36467153-DF18C6A9-B3F1-4EC9-9D80-51A34B794C4EQ36908259-637CCEAD-F4D1-4422-8445-96A02119FCC8Q36910003-DCAF31AF-A375-4F68-A701-6D77694DE691Q38306558-6A4ED5C8-9087-4734-B4C7-796ED420D399Q39280285-D29B15C0-8781-47A3-A5D4-41979B48728FQ39363660-B2508EC3-C6D0-4A3D-B11A-6B07CD827D02Q40110552-14605A48-BF8D-423F-BB1C-55E501F94C14Q41958079-08D0F342-6240-4925-B2F5-F34A4A4BD42EQ42157643-265B70EE-D21E-4C87-B7E8-3B6B56F43013Q44216622-92CF07D6-3847-4408-A931-236A9B18C8C2
P2860
Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Optimization and immune recogn ...... type 1-specific CTL epitopes.
@en
Optimization and immune recogn ...... type 1-specific CTL epitopes.
@nl
type
label
Optimization and immune recogn ...... type 1-specific CTL epitopes.
@en
Optimization and immune recogn ...... type 1-specific CTL epitopes.
@nl
prefLabel
Optimization and immune recogn ...... type 1-specific CTL epitopes.
@en
Optimization and immune recogn ...... type 1-specific CTL epitopes.
@nl
P2093
P50
P356
P1476
Optimization and immune recogn ...... type 1-specific CTL epitopes.
@en
P2093
Dominic Therrien
Gitte Kronborg
Lars Mathiesen
Paul Chaplin
Sanne Lauemoller
Sheila Tang
Sylvie Corbet
P304
P356
10.1099/VIR.0.19152-0
P407
P577
2003-09-01T00:00:00Z